News

TranS1 Inc.a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region, announced today that the Department of Health and Human Services, through the Centers for Medicare and Medicaid Services (CMS), has approved and released the valuation of the Category I Current Procedure Terminology (CPT) code 22586 for pre-sacral interbody single level spinal fusion at L5-S1 to be effective January 1, 2013.
CPT code 22586, which applies to the Company's AxiaLIF 1L+ device, is a bundled lumbar arthrodesis procedure that includes bone graft, posterior instrumentation, and fixation which has been assigned a work RVU of 28.12 for calendar year 2013.

Presenting Companies
Are you a Southeastern-based Medical Device Company or Medical Device Data Systems (MDDS) company seeking corporate funding? SEMDA is now accepting applications for you to present to a broad range of investors ranging from seed funding to angel investors, venture capitalists, private equity firms and corporations seeking new technologies.
Be a part of the Southeast’s most dynamic medical device event uniting industry leaders and investors with the latest in medical device technologies. Apply now.

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the latest data from a pooled analysis of 905 patients treated with the Tryton Side Branch Stent.(TM) Results were presented last week in Miami, Fla., by Joanna J. Wykrzykowska, M.D., Ph.D., of the University of Amsterdam as part of a standing-room-only Transcatheter Cardiovascular Therapeutics (TCT) 2012 satellite symposium co-chaired by Professors Martin B. Leon, M.D., of Columbia University Medical Center in New York and Patrick W. Serruys, M.D., Ph.D., of Erasmus University, Rotterdam, Netherlands.
To read the entire story click here

Micell Technologies, Inc. today announced positive data from two clinical studies of its investigational MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES™), a thin-strut drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating designed to control drug release. Eighteen-month outcomes from the DESSOLVE I trial, and nine-month data supporting all study endpoints in the DESSOLVE II trial, were presented by David Kandzari, M.D., Director of Interventional Cardiology and Chief Scientific Officer for the Piedmont Heart Institute of Atlanta, Ga. These data, presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium held in Miami, Fla., will be available on the TCT website, www.tctmd.com, following the conference.

Ethicon Inc., a division of J&J, is releasing its own line of barbed sutures that are designed to give surgeons more control and flexibility while maintaining the necessary strength to hold tissues together without using knots.
The STRATAFIX Knotless Tissue Control Devices feature barbs spaced 1mm apart spiraling along the length of the string that change direction midway down the suture. This provides surgeons the ability to create continuous and dual layer closures without using knots. Ethicon plans on kicking off the ilne with the release of STRATAFIX Spiral devices later this fall
To read the entire story click here
 

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business today announces the launch of the TRIGEN? Low-Profile Screw - the only truly 'captured' head, low-profile screw on the market.
Patented by Smith & Nephew, 'captured' screws feature heads with internal threads that securely attach the screws to the screwdriver - potentially removing the risk of a screw being lost during surgery. Surgeons interested in learning more about the TRIGEN Low-Profile Screw are invited to visit the Smith & Nephew booth (#606) at this week's Orthopaedic Trauma Association meeting in Minneapolis.
Because low-profile screw heads sit closer to the surface of the bone, they can potentially reduce irritation to the surrounding soft tissue. With the introduction of the TRIGEN Low-profile screw, surgeons are now able to combine the patient-friendly aspects of a lower profile head with the efficiency and security of a captured screw.

North Carolina State University  is heading a nanotechnology research effort, the goal of which is to develop self-powered medical devices. Researchers at the National Science Foundation’s Nanosystems Engineering Research Center for Advanced Self-Powered Systems of Integrated Sensors and Technologies (ASSIST) will use minuscule materials to produce self-powered health monitoring sensors and devices capable of monitoring a range of biological systems. The devices will eventually be available in a variety of forms, including patches worn on the skin, bracelets, or caps to fit over a tooth.
The new devices will generate power based on nanomaterials, nanostructures, thermoelectric materials that use body heat, and piezoelectric materials that use body motion. Thus, changing and recharging batteries will become a thing of the past. In addition, the ASSIST researchers’ hope is that the devices will consume small amounts of energy.

SunTech Medical announced the launch of a new line of reusable cuffs for blood-pressure monitoring in a clinical setting.
The one-piece durable cuff has a nylon shell that is easily cleaned and disinfected to help minimize cross contamination. A tapered tail design allows easy application and eliminates sharp corners, improving patient comfort.
The cuffs are color coded for quick size identification and available with a variety of connector configurations. SunTech Medical also offers a cuff standardization program to standardize facilities to a single connector type.
To read the entire story click here

HyperBranch Medical Technology is one step closer in getting its new surgical sealant to market.
The company announced it has completed patient enrollment in neurosurgery trials for Adherus Dural Sealant. The more than 240 patients treated will be followed for four months to evaluate the sealant’s safety and effectiveness, and then the data will be submitted to the Food and Drug Administration.
To read the entire story click here

Teleflex Incorporated, a provider of medical devices for critical care and surgery, has received the FDA 510(k) clearance to market its pressure injectable ARROW peripherally inserted central catheter preloaded with the ARROW VPS Vascular Positioning System stylet.
The ARROW VPS replaces the need for confirmatory chest X-ray in the presence of a stable Blue Bullseye by using real-time intravascular Doppler, ECG and advanced algorithmic logic to notify the clinician that the catheter tip has reached the optimal location. The preloaded option improves clinician ease of use for vascular navigation and catheter tip positioning.
To read the entire story click here